Completed
Phase 2
Age: 28Years - 47Years
MALE
ID00000187
Ritanserin in Treatment of Cocaine Dependence
Led by University of Pennsylvania · Updated on 2015-05-28
80
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Pennsylvania
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
CONDITIONS
Brief Title
Ritanserin in Treatment of Cocaine Dependence - 1
Who Can Participate
Age: 28Years - 47Years
MALE
Eligibility Criteria
Please contact site for information.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here